These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Interrelation between atherosclerosis and restenosis. Kranzhöfer R; Libby P Z Kardiol; 1995; 84 Suppl 4():125-8. PubMed ID: 8585264 [TBL] [Abstract][Full Text] [Related]
27. Restenosis after coronary angioplasty. Hamon M; Bauters C; McFadden EP; Wernert N; Lablanche JM; Dupuis B; Bertrand ME Eur Heart J; 1995 Aug; 16 Suppl I():33-48. PubMed ID: 8829956 [TBL] [Abstract][Full Text] [Related]
28. [Relationship between morphology of restenosis and clinical aspects in patients who had undergone coronary angioplasty]. Bramucci E; de Servi S; Ghio S; Cioffi P; Angoli L; Barberis P; Ferrario M; Poma E; Ardissino D; Montemartini C G Ital Cardiol; 1988 Oct; 18(10):819-23. PubMed ID: 2977595 [TBL] [Abstract][Full Text] [Related]
29. [Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance]. Alfke H; Böger RH; Bode-Böger SM Vasa; 1996; 25(1):13-20. PubMed ID: 8851261 [TBL] [Abstract][Full Text] [Related]
30. Expanding role of coronary angioplasty: current implications, limitations, and nursing considerations. Sipperly ME Heart Lung; 1989 Sep; 18(5):507-13. PubMed ID: 2528518 [TBL] [Abstract][Full Text] [Related]
31. Restenosis after percutaneous transluminal coronary angioplasty. Kent KM Am J Cardiol; 1988 May; 61(14):67G-70G. PubMed ID: 2966567 [TBL] [Abstract][Full Text] [Related]
33. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. Austin GE; Ratliff NB; Hollman J; Tabei S; Phillips DF J Am Coll Cardiol; 1985 Aug; 6(2):369-75. PubMed ID: 3160756 [TBL] [Abstract][Full Text] [Related]
34. Morphologic observations late after coronary balloon angioplasty: mechanisms of acute injury and relationship to restenosis. Waller BF; Orr CM; Pinkerton CA; VanTassel JW; Pinto RP Radiology; 1990 Mar; 174(3 Pt 2):961-7. PubMed ID: 2406792 [TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses. Haudenschild CC Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039 [TBL] [Abstract][Full Text] [Related]
37. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Landzberg BR; Frishman WH; Lerrick K Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821 [TBL] [Abstract][Full Text] [Related]
38. Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients. Waller BF; McManus BM; Gorfinkel HJ; Kishel JC; Schmidt EC; Kent KM; Roberts WC Am J Cardiol; 1983 Jan; 51(1):81-4. PubMed ID: 6217740 [TBL] [Abstract][Full Text] [Related]
39. A biological basis for re-stenosis after percutaneous transluminal angioplasty: possible underlying mechanisms. Tennant M; McGeachie JK Aust N Z J Surg; 1992 Feb; 62(2):135-41. PubMed ID: 1534008 [TBL] [Abstract][Full Text] [Related]
40. Morphologic correlates of coronary angiographic patterns at the site of percutaneous transluminal coronary angioplasty. Waller BF Clin Cardiol; 1988 Dec; 11(12):817-22. PubMed ID: 2976626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]